Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Patti G, et al. Among authors: di sciascio g. J Am Coll Cardiol. 2008 Sep 30;52(14):1128-33. doi: 10.1016/j.jacc.2008.06.038. J Am Coll Cardiol. 2008. PMID: 18804738 Free article. Clinical Trial.
Statin loading for acute coronary syndromes.
Nusca A, Melfi R, Patti G, Di Sciascio G. Nusca A, et al. Among authors: di sciascio g. Curr Opin Cardiol. 2010 Jul;25(4):373-8. doi: 10.1097/HCO.0b013e32833987ca. Curr Opin Cardiol. 2010. PMID: 20520540 Review.
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention.
Mangiacapra F, Patti G, Peace A, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Muller O, Barbato E, Di Sciascio G. Mangiacapra F, et al. Among authors: di sciascio g. Am J Cardiol. 2010 Sep 1;106(5):619-23. doi: 10.1016/j.amjcard.2010.04.015. Am J Cardiol. 2010. PMID: 20723634
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G. Patti G, et al. Among authors: di sciascio g. Am J Cardiol. 2011 Apr 1;107(7):995-1000. doi: 10.1016/j.amjcard.2010.11.025. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256470
High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study.
Patti G, Grieco D, Dicuonzo G, Pasceri V, Nusca A, Di Sciascio G. Patti G, et al. Among authors: di sciascio g. J Am Coll Cardiol. 2011 Feb 15;57(7):771-8. doi: 10.1016/j.jacc.2010.09.050. J Am Coll Cardiol. 2011. PMID: 21310311 Free article. Clinical Trial.
276 results